Sanofi eyes filings for multiple sclerosis therapy tolebrutinib, although two of three phase 3 trials miss their primary endpoints.

Detailed price information for Johnson & Johnson (JNJ-N) from The Globe and Mail including charting and trades.

Two veteran biotech investors have reunited to form a new venture capital firm focusing on autoimmune diseases. Steven St. | ...

Denali Therapeutics, Inc. DNLI announced that the FDA has accepted for review its biologics license application (BLA) for ...

Marisa Wexler is a senior science writer for Multiple Sclerosis News Today with an MS in cellular and molecular pathology. She covers the latest news and information on a variety of multiple ...

A study led by Cambridge researchers has shed light on how neural stem cell grafts could help restore myelin in the central ...

Researchers at the Karolinska Institute in Sweden have identified 18 new potential drug targets for treating multiple ...

A study led by Cambridge researchers has shed light on how neural stem cell grafts could help restore myelin in the central ...

Vaccination against COVID-19 is crucial for individuals with multiple sclerosis (MS), ensuring safety and effectiveness despite immunosuppressive therapies.

A new study reveals that neural stem cell grafts can generate new myelin in the central nervous system, offering hope for ...

Multiple sclerosis articles from across Nature Portfolio Multiple sclerosis is an autoimmune disease in which immune cells attack and destroy the protective myelin sheaths that surround nerve ...

Explore Our Free-Market Analysis Sample – Instant Access: – https://www.astuteanalytica.com/request-sample/amyotrophic-lateral-sclerosis-treatment-market ...